HLA-DQ2 is a well-established genetic marker for celiac disease, an autoimmune condition affecting the gut. About 25–30 % of the population carry HLA-DQ2, but only a minority develop celiac disease. Testing for HLA-DQ2 is clinically useful to rule out celiac disease: if both HLA-DQ2 and HLA-DQ8 are absent, the likelihood of celiac disease is extremely low. However, a positive result alone does not diagnose celiac disease; it must be combined with serology (tTG-IgA) and biopsy. For general gut health (e.g., bloating, IBS, microbiome balance), HLA-DQ2 has limited utility because it does not predict non-celiac gluten sensitivity or other functional disorders. The evidence is human-strong for celiac risk association, but not for broader gut health claims. Caveat: Direct-to-consumer genetic tests may overstate the relevance; always consult a gastroenterologist for interpretation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-66bce6e04604c1245674b925